Bicarbonate transporter SLC4A7 promotes EMT and metastasis of HNSCC by activating the PI3K/AKT/mTOR signaling pathway
Molecular Carcinogenesis · 2023
DOI: 10.1002/mc.23511 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Carcinogenesis, 2023. Verfasst von Junli Hu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Head and Neck Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 39 Literaturangaben.
Abstract (Originalsprache)
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide. Currently, therapeutic modalities such as surgery, chemotherapy, radiotherapy, and immunotherapy are being used to treat HNSCC. However, the treatment outcomes of most patients are dismal because they are already in middle or advanced stage by the time of diagnosis and poorly responsive to treatments. It is therefore of great interest to clarify mechanisms that contribute to the metastasis of cells to identify possible targets for therapy. In this study, we identified the Na + ‐coupled bicarbonate transporter, SLC4A7, play essential roles in the metastasis of HNSCC. Our results showed that the relative expression of SLC4A7 messenger RNA was highly expressed in HNSCCs samples from TCGA, and compared with precancerous cells of human oral mucosa (DOK), SLC4A7 was highly expressed in HNSCC cell lines. In vitro and in vivo experiments showed that dysregulation of SLC4A7 had minor influence on the proliferation of HNSCC but impacted HNSCC's migration and invasion. Meanwhile, SLC4A7 could promote epithelial‐mesenchymal transition (EMT) in HNSCC. RNA‐seq, KEGG pathway enrichment analysis and Western blot further revealed that downregulation of SLC4A7 in HNSCC cells inhibited the PI3K/AKT pathway. These findings were further validated via rescue experiments using a small molecule inhibitor of PI3K/mTOR (GDC‐0980). Our findings suggest that SLC4A7 promotes EMT and metastasis of HNSCC through the PI3K/AKT/mTOR signaling pathway, which may be a valuable predictive biomarker and potential therapeutic target in HNSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital, Central South University, Changsha, China.
- Otolaryngology Major Disease Research Key Laboratory of Hunan Province, Changsha, China.
- Clinical Research Center for Pharyngolaryngeal Diseases and Voice Disorders in Hunan Province, Changsha, China.
- Department of Otolaryngology Head and Neck Surgery, Yantian District People's Hospital, Shenzhen, Guangdong, China.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China.
ORCID-Profile: Chao Liu
Zitieren
APA
Hu, J., Li, G., Liu, Z., Ma, H., Yuan, W., Lu, Z., Zhang, D., Ling, H., Zhang, F., Liu, Y., Liu, C., & Qiu, Y. (2023). Bicarbonate transporter SLC4A7 promotes EMT and metastasis of HNSCC by activating the PI3K/AKT/mTOR signaling pathway. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23511
Vancouver
Hu J, Li G, Liu Z, Ma H, Yuan W, Lu Z, et al. Bicarbonate transporter SLC4A7 promotes EMT and metastasis of HNSCC by activating the PI3K/AKT/mTOR signaling pathway. Molecular Carcinogenesis. 2023. doi:10.1002/mc.23511
BibTeX
@article{Hu2023,
author = {Hu, Junli and Li, Guo and Liu, Zhifeng and Ma, Huiling and Yuan, Wenhui and Lu, Zhaoyi and Zhang, Diekuo and Ling, Hang and Zhang, Fengyu and Liu, Yong and Liu, Chao and Qiu, Yuanzheng},
title = {Bicarbonate transporter SLC4A7 promotes EMT and metastasis of HNSCC by activating the PI3K/AKT/mTOR signaling pathway},
journal = {Molecular Carcinogenesis},
year = {2023},
doi = {10.1002/mc.23511}
}
EUVIMED